Wednesday, May 16, 2012

Malaria Drug Research Wins Gates Foundation Award

Jay Keasling, Berkeley Lab’s Associate Lab Director for Biosciences and CEO of the Joint BioEnergy Institute (JBEI), is the principal investigator for Zagaya, a non-profit organization dedicated to making malaria treatments accessible to the developing world. Keasling and Zagaya have been named Round 8 winners of Grand Challenges Explorations, an initiative funded by the Bill & Melinda Gates Foundation. The $100,000 award is for development of a technique whereby artemisin, a powerful anti-malaria drug, could be produced in the dark from an endophytic fungus. If the fungus can be induced to produce artemisinin in the absence of light, an enzymatic mechanism could be harnessed for a new production method to reduce treatment costs for malaria patients in developing countries.

Read More>> Best Blogger Tips

Blogger Tips - Get This Gadget